Skip to ContentSkip to Navigation
About us Latest news News News articles

Getting grip on glucocorticoid-induced metabolic derangements

08 February 2012

PhD ceremony: Ms. A.J. Laskewitz, 16.15 uur, Aula Academiegebouw, Broerstraat 5, Groningen

Dissertation: Getting grip on glucocorticoid-induced metabolic derangements

Promotor(s): prof. F. Kuipers, prof. A.K. Groen

Faculty: Medical Sciences

Synthetic glucocorticoids, such as prednisolone, are potent anti-inflammatory agents which are widely prescribed for the treatment of chronic inflammatory diseases. Unfortunately, these drugs can elicit severe adverse effects, many of which resemble features of the metabolic syndrome such as hyperglycemia, insulin resistance and dyslipidemia. The work described in this thesis focused on the metabolic adverse effects of prednisolone treatment in mice and aimed to unravel the (molecular) mechanisms of these effects in appropriate mouse models using stable isotope methodologies.

A series of novel stable isotope methods to evaluate glucose metabolism in a fasted state were developed and applied in various groups of mice, all treated with vehicle or prednisolone. Surprisingly, in neither model a ‘classical insulin resistance’ could be detected, although the mice showed distinct metabolic derangements upon prednisolone treatment. In addition, a novel non-steroidal glucocorticoid receptor-selective compound was evaluated in these mouse models and was found to show less side effects. Finally, the origin of prednisolon-induced dyslipidemia was examined in mice with a dimerization-defective glucocorticoid receptor.

The in vivo studies described in this thesis provide in-depth analyses of the effects of glucocorticoids on glucose and lipid metabolism and on insulin sensitivity in mice and contribute to an improved understanding of glucocorticoid-induced side effects. They provide an important step in the recognition of the value of mouse models to evaluate glucocorticoid-related adverse effects.

Last modified:13 March 2020 01.01 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...